OPTIMIZERx Completes Capital Funding Transaction to Support Growth Plans
20 Oktober 2008 - 10:05PM
Business Wire
OPTIMIZERx Corporation (Pink Sheets:OPRX) announced September 10,
2008 that it has completed a $3.5 million corporate financing
transaction to further support its growth plans of
www.OPTIMIZERx.com and to accelerate the rollout of its marketing
platforms, including the recently introduced OFFERx(TM) and the
soon to be launched ADHERxE(TM) platforms. The $3.5mm was
structured as preferred shares which are convertible into common
shares; the investor also received warrants in the deal. The
financing was placed by Midtown Partners & Co., LLC
(www.midtownpartners.com), a FINRA member & SIPC Broker/Dealer.
OPTIMIZERx.com has quickly established itself as the online leader
for providing patients a central way to access and enroll in over
150 savings and support programs from leading prescription brands.
In turn, OPTIMIZERx provides pharmaceutical and healthcare brands
unique advertising solutions to directly engage motivated health
consumers looking for their type of products and support.
OFFERx(TM) provides a single, turn-key platform to allow more
pharmaceutical and healthcare companies to develop, test and expand
superior patient savings and support programs on a faster and more
cost-effective basis. The company's upcoming launch of ADHERxE(TM)
will also provide turn-key solutions to address the pharmaceutical
industry's number one challenge: helping patients stay on their
medicines longer. The ADHERxE(TM) platform will soon allow leading
Rx brands to turn their patient offers into powerful compliance
programs that include surveying patient results each month in
exchange for re-activation of their co-pay card. This program
allows the brand to regularly engage the patient and helps minimize
any barriers on maintaining treatments for important chronic
therapies. About OPTIMIZERx Corporation OPTIMIZERx provides unique
platforms to help patients better afford and comply to their
medicines and healthcare products, while offering pharmaceutical
and healthcare companies effective ways to expand patient
awareness, access and adherence to their brands. The Company's
web-based consumer information and patient support website,
www.OPTIMIZERx.com, and its permanent subscriber base, continues to
grow each month and is quickly becoming the preferred way to access
branded prescription savings and support programs. Additionally,
OPTIMIZERx has integrated and developed peripheral offerings and
capabilities, most obviously the newly launched OFFERx(TM) offer
management system to allow more brands to participate in promoting
a new trial or co-pay program, as well as sophisticated online
behavioral re-targeting and database marketing of brand-name
pharmaceuticals, OTC medications, medical devices, and healthcare
services that provide OPTIMIZERx visitors and subscribers the
highest possible value and the best possible medical outcome for
their specific condition. 'Safe Harbor' This press release contains
forward-looking statements within the definition of Section 27A of
the Securities Act of 1933, as amended and such section 21E of the
Securities Act of 1934, amended. These forward-looking statements
should not be used to make an investment decision. The words
'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition and other material.
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024